ConductScience.org, home

Paper9753714

Treatment of breast cancer.

Hortobagyi GN. N Engl J Med, 1998. Cited by 599 papers, by iCite.

Cite this record

ConductScience Library. Treatment of breast cancer. Papers, record 9753714. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9753714

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of breast cancer.
PubMed
Journal
N Engl J Med
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
599
iCite
Relative citation ratio, by iCite
14.3
iCite
Revised in PubMed
2022-04-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hortobagyi GNG N

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Breast NeoplasmsMajor topic
Female
Humans
Neoplasm Metastasis
Palliative Care
Tamoxifen

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in9935350Treatment of breast cancer.https://conductscience.org/library/papers/9935350PubMed
Comment in9935351Treatment of breast cancer.https://conductscience.org/library/papers/9935351PubMed

Download CSV of comments and corrections

Cited by188

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 599 citations.

PMIDTitleJournalYearIn PapersSource
42362517TFCP2L1 suppresses breast cancer progression by promoting ferroptosis through direct and PI3K/AKT-mediated inhibition of GPX4.Cell Death Discov2026https://conductscience.org/library/papers/42362517PubMed
41158206The role of genetics and epigenetics in breast cancer: A comprehensive review of metastasis, risk factors, and future perspectives.J Pharm Anal2025https://conductscience.org/library/papers/41158206PubMed
40196294Chemoinformatics analysis of Mangifera indica leaves extracted phytochemicals as potential EGFR kinase modulators.Front Chem2025https://conductscience.org/library/papers/40196294PubMed
39926152Effectiveness of Automated Treatment Planning for Left-sided Breast in Flattening Filter-free Photon Beams.J Med Phys2024https://conductscience.org/library/papers/39926152PubMed
39893610The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer.Breast Cancer2025https://conductscience.org/library/papers/39893610PubMed
39179606Ergosterol inhibits the proliferation of breast cancer cells by suppressing AKT/GSK-3beta/beta-catenin pathway.Sci Rep2024https://conductscience.org/library/papers/39179606PubMed
39144248Multidisciplinary Treatment for Locally Advanced Mucinous Breast Cancer.Case Rep Oncol2024https://conductscience.org/library/papers/39144248PubMed
39042910New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.J Med Chem2024https://conductscience.org/library/papers/39042910PubMed
38947759Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning.Cancer Innov2024https://conductscience.org/library/papers/38947759PubMed
38615110Unraveling the anti-breast cancer activity of Cimicifugae rhizoma using biological network pathways and molecular dynamics simulation.Mol Divers2025https://conductscience.org/library/papers/38615110PubMed
38404689Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment.Front Cell Dev Biol2024https://conductscience.org/library/papers/38404689PubMed
37881785Methylation of ESR1 promoter induced by SNAI2-DNMT3B complex promotes epithelial-mesenchymal transition and correlates with poor prognosis in ERα-positive breast cancers.MedComm (2020)2023https://conductscience.org/library/papers/37881785PubMed
37861041Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer.Comb Chem High Throughput Screen2024https://conductscience.org/library/papers/37861041PubMed
37763624Osteoporosis Associated with Breast Cancer Treatments Based on Types of Hormonal Therapy: A Cross-Sectional Study Using Korean National Sample Data.Medicina (Kaunas)2023https://conductscience.org/library/papers/37763624PubMed
37596450Great Debate: The Surgeon's Role in Locoregional Management of Stage IV Breast Cancer.Ann Surg Oncol2023https://conductscience.org/library/papers/37596450PubMed
37581480Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancer.J Cell Mol Med2023https://conductscience.org/library/papers/37581480PubMed
37446109Efficacy of Green Synthesized Nanoparticles in Photodynamic Therapy: A Therapeutic Approach.Int J Mol Sci2023https://conductscience.org/library/papers/37446109PubMed
37428338Latissimus dorsi musculocutaneous flap grafting to the infected recipient site in a patient with irradiated locally advanced breast cancer and multiple lung metastases.Surg Case Rep2023https://conductscience.org/library/papers/37428338PubMed
37231732Hypothesizing the Green Synthesis of Tamoxifen Loaded Magnetic Nanoparticles for the Treatment of Breast Cancer.Curr Mol Med2024https://conductscience.org/library/papers/37231732PubMed
37200812Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer.ACS Pharmacol Transl Sci2023https://conductscience.org/library/papers/37200812PubMed

See all 188 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9753714

GET https://conductscience.org/api/papers/v1/9753714/cited_by?page=2